SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021

• Published in: Emerging infectious diseases Vol. 28; no. 6; pp. 1279 - 1280
• Main Authors: Harris, Julie R, Owusu, Daniel, O'Laughlin, Kevin, Cohen, Adam L, Ben Hamida, Amen, Patel, Jaymin C, Freeman, Molly M, Nsibambi, Thomas, Nieves, Rebecca, Marston, Barbara J, Wasike, Samuel, Galbraith, Jennifer S, Boore, Amy L, Nelson, Lisa J, Guagliardo, Sarah Anne J, Klena, John D, Patel, Ketan, Ma, Marek
• Format: Journal Article
• Language: English
• Published: United States U.S. National Center for Infectious Diseases 01-06-2022; Centers for Disease Control and Prevention
• Subjects: 2021 AD; Americans in foreign countries; coronavirus disease; Coronaviruses; COVID-19; COVID-19 vaccines; Diplomatic & consular services; Embassy buildings; Epidemics; Health aspects; Immunization; Public employees; Research Letter; respiratory infections; Risk factors; SARS; SARS-CoV-2; severe acute respiratory syndrome coronavirus 2; Statistics; Uganda; Uganda; Atlanta Georgia; Georgia; United States > US; Kampala Uganda; India; viruses; breakthrough; SARS; US Embassy; coronavirus; zoonoses; respiratory infections; COVID-19; SARS-CoV-2; vaccine; severe acute respiratory syndrome coronavirus 2; Uganda; coronavirus disease
• ISSN: 1080-6040; 1080-6059
• DOI: 10.3201/eid2806.220427

The SARS-CoV-2 Delta variant emerged shortly after COVID-19 vaccines became available in 2021. We describe SARS-CoV-2 breakthrough infections in a highly vaccinated, well-monitored US Embassy community in Kampala, Uganda. Defining breakthrough infection rates in highly vaccinated populations can help determine public health messaging, guidance, and policy globally.